Drug Company Seeks Review Of Cancer Treatment Patent, Joinder With Other Case

(January 18, 2018, 3:45 PM EST) -- ALEXANDRIA, Va. —West-Ward Pharmaceutical Co. on Jan. 17 took aim at a cancer treatment patent while also requesting joinder to an inter partes review (IPR) by Breckenridge Pharmaceutical Inc., in which...
To view the full article, register now.